Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

Antimicrobial Agents and Chemotherapy
Kyle D SmithASTRO-CM/COAT Team

Abstract

Cryptococcal antigen screening is recommended among people living with AIDS when entering HIV care with a CD4 count of <100 cells/μl, and preemptive fluconazole monotherapy treatment is recommended for those with subclinical cryptococcal antigenemia. Yet, knowledge is limited of current antimicrobial resistance in Africa. We examined antifungal drug susceptibility in 198 clinical isolates collected from Kampala, Uganda, between 2010 and 2014 using the CLSI broth microdilution assay. In comparison with two previous studies from 1998 to 1999 that reported an MIC50 of 4 μg/ml and an MIC90 of 8 μg/ml prior to widespread human fluconazole and agricultural azole fungicide usage, we report an upward shift in the fluconazole MIC50 to 8 μg/ml and an MIC90 value of 32 μg/ml, with 31% of isolates with a fluconazole MIC of ≥ 16 μg/ml. We observed an amphotericin B MIC50 of 0.5 μg/ml and an MIC90 of 1 μg/ml, of which 99.5% of isolates (197 of 198 isolates) were still susceptible. No correlation between MIC and clinical outcome was observed in the context of amphotericin B and fluconazole combination induction therapy. We also analyzed Cryptococcus susceptibility to sertraline, with an MIC50 of 4 μg/ml, suggesting that sertraline is a promis...Continue Reading

References

Feb 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D WittM A Ghannoum
May 19, 2000·Antimicrobial Agents and Chemotherapy·A I AllerA Espinel-Ingroff
Jun 26, 2003·Trends in Microbiology·Frank C OddsNeil A R Gow
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tihana BicanicThomas Harrison
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicky LongleyThomas S Harrison
Apr 15, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tihana BicanicThomas Harrison
Nov 21, 2009·The Lancet Infectious Diseases·Paul E VerweijWillem J G Melchers
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David B MeyaDavid R Boulware
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kaitlyn C GrayMartin D Burke
Mar 6, 2012·Current Fungal Infection Reports·Darin L Wiesner, David R Boulware
Mar 14, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Radha RajasinghamDavid R Boulware
Apr 18, 2012·Antimicrobial Agents and Chemotherapy·Bing ZhaiXiaorong Lin
Dec 21, 2012·Science Translational Medicine·Gordon D BrownTheodore C White
Apr 5, 2013·The New England Journal of Medicine·Jeremy N DayJeremy J Farrar
Jun 6, 2013·The Lancet Infectious Diseases·Angela LoyseTihana Bicanic
Dec 10, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph N JarvisThomas Harrison
Jun 26, 2014·The New England Journal of Medicine·David R BoulwareUNKNOWN COAT Trial Team

❮ Previous
Next ❯

Citations

May 3, 2016·Mycoses·Franqueline Reichert-LimaAngelica Z Schreiber
Mar 14, 2016·The Lancet Infectious Diseases·Joshua RheinUNKNOWN ASTRO-CM Study Team
Sep 2, 2016·Medical Mycology Journal·Norihito TarumotoShigefumi Maesaki
Jan 24, 2017·Expert Review of Anti-infective Therapy·Sarah LofgrenDavid R Boulware
Apr 20, 2017·Revista Do Instituto De Medicina Tropical De São Paulo·Paula Augusta Dias Fogaça de AguiarDenise Von Dolinger de Brito Röder
Sep 30, 2016·Revista Do Instituto De Medicina Tropical De São Paulo·Thais Pandini FigueiredoClaudia Maria Leite Maffei
May 13, 2017·Nature Reviews. Drug Discovery·John R Perfect
Dec 3, 2016·AIDS Research and Therapy·Sirawat Srichatrapimuk, Somnuek Sungkanuparph
Feb 23, 2018·Medical Mycology·Nívea Pereira de SáSusana Johann
May 9, 2018·Current Opinion in Infectious Diseases·Andrés F Henao-MartínezCarlos Franco-Paredes
Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Jessica L ChittyAvril A B Robertson
Mar 23, 2019·Clinical Transplantation·John W BaddleyUNKNOWN AST Infectious Diseases Community of Practice
Nov 19, 2019·PLoS Neglected Tropical Diseases·Fulgence Kondo KassiSébastien Bertout
May 12, 2018·International Journal of STD & AIDS·Thilinie D BandaranayakeMerceditas S Villanueva
Jun 13, 2020·The Journal of International Medical Research·Ming YangPeiyuan Xia
Jun 13, 2020·The Journal of International Medical Research·Huan-Huan WuShuang-Yan Fang
Jul 23, 2020·Molecular Microbiology·Arianne Bermas, Jennifer Geddes-McAlister
Aug 22, 2020·Medical Mycology·Chi-Jan LinYing-Lien Chen
Nov 2, 2019·MSphere·Suresh AmbatiRichard B Meagher
Dec 20, 2019·MSphere·Alexis GarciaSoo Chan Lee
Mar 20, 2019·Medical Mycology·Hellem Cristina Silva CarneiroDaniel Assis Santos
Mar 21, 2020·Microbial Cell Factories·Falicia GohSiew Bee Ng
May 20, 2020·Frontiers in Cellular and Infection Microbiology·Minji ParkWon Hee Jung
Sep 9, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Si-Ying WuYing Ma
Apr 1, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Somnuek SungkanuparphWarisara Pattanapongpaiboon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Antimicrobial Agents and Chemotherapy
Nelesh P GovenderGroup for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA)
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Alicia Gomez-LopezManuel Cuenca-Estrella
© 2021 Meta ULC. All rights reserved